210 Followers on Owler
ORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications...
Read moreORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications...
Read more
2014
PrivateIndependent Company
News
Oct 16, 2020
The Business Journals
ORIG3N: Boston lab faces penalties after Covid test errors
Sep 08, 2020
CBS BOSTON
ORIG3N: Massachusetts Stops Coronavirus Testing At Boston Lab After 383 False Positives Found
Sep 04, 2020
Telegram & Gazette
ORIG3N: Boston startup Orig3n logged hundreds of false-positives as it processed COVID tests for dozens of long-term care facilities. Now, the company is under investigation
Jun 23, 2020
StreetInsider
Press Release: ORIG3N : Orig3n Announces Comprehensive Solution To Provide COVID-19 Testing For Boarding Schools
May 27, 2020
PR Newswire
Press Release: ORIG3N : Orig3n Announces Comprehensive Solution To Provide COVID-19 Testing For The New England Power Generators Association
May 12, 2020
PR Newswire
Press Release: ORIG3N : Orig3n Announces Comprehensive Solution To Enable COVID-19 Testing Of Massachusetts Nursing Home Residents
Apr 14, 2020
Medical Buyer
ORIG3N: Orig3n Gets FDA EUA Status For COVID-19 Test
Apr 02, 2020
BioSpace
ORIG3N: Orig3n Announces Partnership with Codex Beauty
Dec 17, 2019
PR Newswire
Press Release: ORIG3N : Stratify Genomics and Orig3n sign commercial partnership
Nov 13, 2019
StreetInsider
Press Release: ORIG3N : Orig3n Announces Customized Vitamin Partnership with VitaminLab and Launch of New Vitamin Genetic Test Kit
ORIG3N Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to ORIG3N?
ORIG3N News
ORIG3N Blogs
ORIG3N Press Releases
ORIG3N Videos
ORIG3N Headquarters
ORIG3N Summary
ABOUT
Overview
ORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications. ORIG3N was founded in 2014. ORIG3N's headquarters is located in Boston, Massachusetts, USA 02210. ORIG3N's Co-Founder &...CEO
ORIG3N's Co-Founder & CEO, Robin Y. Smith, currently has an approval rating of 80%. ORIG3N's primary competitors are Ultragenyx, Qrativ & Sarepta Therapeutics.Website
orig3n.comCompetitors
View 24 ORIG3N competitors here.Acquisitions
View 1 companies acquired by ORIG3N here.Funding
View ORIG3N funding details.Investments
Recent investment data cannot be found related to ORIG3NFrequently Asked Questions about ORIG3N
When was ORIG3N founded?
ORIG3N was founded in 2014Who is ORIG3N's CEO?
ORIG3N's CEO is Robin Y. SmithHow much revenue does ORIG3N generate?
ORIG3N generates $3M in revenueHow much funding does ORIG3N have?
ORIG3N has historically raised $36M in funding
Where is ORIG3N's headquarters?
ORIG3N's headquarters is in Boston Massachusetts, USAHow many employees does ORIG3N have?
ORIG3N has 60 employeesWhat sector does ORIG3N operate in?
ORIG3N is in BiotechnologyWho are ORIG3N's competitors?
ORIG3N's top competitors are Ultragenyx, Qrativ, Sarepta Therapeutics